The ROSI study (risedronate in adults with osteogenesis imperfecta type 1)
Main Authors: | Duncan, E, Bradbury, L, Barlow, S, Geoghenan, F, Blumsohn, A, Schofield, P, Wass, J, Russell, R, Brown, M |
---|---|
Format: | Conference item |
Published: |
2005
|
Similar Items
-
The ROSI study (Risedronate in adults with osteogenesis imperfecta type 1): Improved BMD but high fracture rate persists.
by: Bradbury, L, et al.
Published: (2006) -
Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists.
by: Bradbury, L, et al.
Published: (2012) -
Fatigue in adults with Osteogenesis Imperfecta
by: Arjan G. J. Harsevoort, et al.
Published: (2020-01-01) -
Osteogénesis imperfecta
by: Ernesto Plata Rueda
Published: (1952-07-01) -
Osteogenesis imperfecta
by: Justin Easow Sam, et al.
Published: (2017-01-01)